US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist

1.2300
-0.0300-2.38%

Close Nov 21 16:00 ET

1.2300
0.00000.00%

Post 20:01 ET

3.03MMarket Cap-350P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-54.30%951.02K

-73.37%809.67K

-71.29%903.54K

157.24%9.43M

-9.87%1.16M

70.67%2.08M

547.74%3.04M

356.50%3.15M

232.27%3.67M

179.51%1.29M

Selling and administrative expenses

3.01%521.27K

-38.33%459.22K

18.14%657.91K

20.84%2.52M

34.21%712.93K

12.49%506.04K

64.85%744.62K

-14.73%556.89K

104.29%2.09M

24.71%531.21K

-General and administrative expense

3.01%521.27K

-38.33%459.22K

18.14%657.91K

20.84%2.52M

34.21%712.93K

12.49%506.04K

64.85%744.62K

-14.73%556.89K

104.29%2.09M

24.71%531.21K

Research and development costs

-72.71%429.75K

-84.73%350.44K

-90.52%245.63K

337.40%6.91M

-40.85%447.08K

104.68%1.57M

12,941.20%2.3M

7,017.16%2.59M

1,824.94%1.58M

2,089.20%755.89K

Operating profit

54.30%-951.02K

73.37%-809.67K

71.29%-903.54K

-157.24%-9.43M

9.87%-1.16M

-70.67%-2.08M

-547.74%-3.04M

-356.50%-3.15M

-232.27%-3.67M

-179.51%-1.29M

Net non-operating interest income expense

3,630.04%19.99K

3,439.02%15.15K

-54.14%255

100.26%1.87K

100.05%349

536

428

556

9.12%-731.71K

-4,859.09%-731.71K

Non-operating interest income

3,630.04%19.99K

3,439.02%15.15K

-54.14%255

--1.87K

--349

--536

--428

--556

--0

Total other finance cost

----

--731.71K

----

Other net income (expense)

-106.21%-9.97K

-99.15%10.79K

106.63%37.31K

-83.60%477.7K

-390.23K

160.65K

1.27M

-562.92K

878.91%2.91M

Gain on sale of security

-106.21%-9.97K

-99.15%10.79K

106.63%37.31K

-69.35%892.69K

--24.76K

--160.65K

--1.27M

---562.92K

--2.91M

----

Special income (charges)

----

---414.99K

----

--0

----

-Less:Other special charges

----

--414.99K

----

Income before tax

50.98%-941K

55.70%-783.73K

76.66%-865.97K

-502.76%-8.95M

-273.47%-1.55M

-57.45%-1.92M

-276.99%-1.77M

-438.06%-3.71M

7.83%-1.48M

602.69%893.46K

Income tax

Net income

50.98%-941K

55.70%-783.73K

76.66%-865.97K

-502.76%-8.95M

-273.47%-1.55M

-57.45%-1.92M

-276.99%-1.77M

-438.06%-3.71M

7.83%-1.48M

602.69%893.46K

Net income continuous Operations

50.98%-941K

55.70%-783.73K

76.66%-865.97K

-502.76%-8.95M

-273.47%-1.55M

-57.45%-1.92M

-276.99%-1.77M

-438.06%-3.71M

7.83%-1.48M

602.69%893.46K

Minority interest income

Net income attributable to the parent company

50.98%-941K

55.70%-783.73K

76.66%-865.97K

-502.76%-8.95M

-273.47%-1.55M

-57.45%-1.92M

-276.99%-1.77M

-438.06%-3.71M

7.83%-1.48M

602.69%893.46K

Preferred stock dividends

Other preferred stock dividends

3.21M

Net income attributable to common stockholders

-116.36%-4.15M

55.70%-783.73K

76.66%-865.97K

-502.76%-8.95M

-273.47%-1.55M

-57.45%-1.92M

-276.99%-1.77M

-438.06%-3.71M

7.83%-1.48M

602.69%893.46K

Basic earnings per share

51.63%-2.37

87.14%-0.67

97.63%-1.31

-9.18%-34.01

-112.10%-2.9011

82.65%-4.9

52.11%-5.21

-228.57%-55.2

62.92%-31.15

681.62%23.97

Diluted earnings per share

51.63%-2.37

87.14%-0.67

97.63%-1.31

-9.18%-34.01

-112.10%-2.9011

82.65%-4.9

52.11%-5.21

-228.57%-55.2

62.92%-31.15

681.62%23.97

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit	0					0
Operating expense	-54.30%951.02K	-73.37%809.67K	-71.29%903.54K	157.24%9.43M	-9.87%1.16M	70.67%2.08M	547.74%3.04M	356.50%3.15M	232.27%3.67M	179.51%1.29M
Selling and administrative expenses	3.01%521.27K	-38.33%459.22K	18.14%657.91K	20.84%2.52M	34.21%712.93K	12.49%506.04K	64.85%744.62K	-14.73%556.89K	104.29%2.09M	24.71%531.21K
-General and administrative expense	3.01%521.27K	-38.33%459.22K	18.14%657.91K	20.84%2.52M	34.21%712.93K	12.49%506.04K	64.85%744.62K	-14.73%556.89K	104.29%2.09M	24.71%531.21K
Research and development costs	-72.71%429.75K	-84.73%350.44K	-90.52%245.63K	337.40%6.91M	-40.85%447.08K	104.68%1.57M	12,941.20%2.3M	7,017.16%2.59M	1,824.94%1.58M	2,089.20%755.89K
Operating profit	54.30%-951.02K	73.37%-809.67K	71.29%-903.54K	-157.24%-9.43M	9.87%-1.16M	-70.67%-2.08M	-547.74%-3.04M	-356.50%-3.15M	-232.27%-3.67M	-179.51%-1.29M
Net non-operating interest income expense	3,630.04%19.99K	3,439.02%15.15K	-54.14%255	100.26%1.87K	100.05%349	536	428	556	9.12%-731.71K	-4,859.09%-731.71K
Non-operating interest income	3,630.04%19.99K	3,439.02%15.15K	-54.14%255	--1.87K	--349	--536	--428	--556	--0	--0
Total other finance cost	----	----	----	----	----	----	----	----	--731.71K	----
Other net income (expense)	-106.21%-9.97K	-99.15%10.79K	106.63%37.31K	-83.60%477.7K	-390.23K	160.65K	1.27M	-562.92K	878.91%2.91M
Gain on sale of security	-106.21%-9.97K	-99.15%10.79K	106.63%37.31K	-69.35%892.69K	--24.76K	--160.65K	--1.27M	---562.92K	--2.91M	----
Special income (charges)	----	----	----	---414.99K	----	----	----	----	--0	----
-Less:Other special charges	----	----	----	--414.99K	----	----	----	----	----	----
Income before tax	50.98%-941K	55.70%-783.73K	76.66%-865.97K	-502.76%-8.95M	-273.47%-1.55M	-57.45%-1.92M	-276.99%-1.77M	-438.06%-3.71M	7.83%-1.48M	602.69%893.46K
Income tax
Net income	50.98%-941K	55.70%-783.73K	76.66%-865.97K	-502.76%-8.95M	-273.47%-1.55M	-57.45%-1.92M	-276.99%-1.77M	-438.06%-3.71M	7.83%-1.48M	602.69%893.46K
Net income continuous Operations	50.98%-941K	55.70%-783.73K	76.66%-865.97K	-502.76%-8.95M	-273.47%-1.55M	-57.45%-1.92M	-276.99%-1.77M	-438.06%-3.71M	7.83%-1.48M	602.69%893.46K
Minority interest income
Net income attributable to the parent company	50.98%-941K	55.70%-783.73K	76.66%-865.97K	-502.76%-8.95M	-273.47%-1.55M	-57.45%-1.92M	-276.99%-1.77M	-438.06%-3.71M	7.83%-1.48M	602.69%893.46K
Preferred stock dividends
Other preferred stock dividends	3.21M					0
Net income attributable to common stockholders	-116.36%-4.15M	55.70%-783.73K	76.66%-865.97K	-502.76%-8.95M	-273.47%-1.55M	-57.45%-1.92M	-276.99%-1.77M	-438.06%-3.71M	7.83%-1.48M	602.69%893.46K
Basic earnings per share	51.63%-2.37	87.14%-0.67	97.63%-1.31	-9.18%-34.01	-112.10%-2.9011	82.65%-4.9	52.11%-5.21	-228.57%-55.2	62.92%-31.15	681.62%23.97
Diluted earnings per share	51.63%-2.37	87.14%-0.67	97.63%-1.31	-9.18%-34.01	-112.10%-2.9011	82.65%-4.9	52.11%-5.21	-228.57%-55.2	62.92%-31.15	681.62%23.97
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data